Skip to main content

Table 4 Description of clinical trial phases

From: Nanomedicine review: clinical developments in liposomal applications

Phase

No. of patientsb

Durationa

Descriptiona

I

< 25

Several months

Safety and dosage

II

25–100

Several months to 2 years

Efficacy and side effects

III

At least several hundred

1–4 years

Efficacy and monitoring of adverse reactions

IV

Several thousand

 > 4 years

Safety and efficacy

  1. aAccording to FDA (2018)
  2. bAccording to American Cancer Society (2018)
Back to article page

Cancer Nanotechnology

ISSN: 1868-6966

Contact us